Daptomycin Pharmacokinetics and Safety following Administration of Escalating Doses Once Daily to Healthy Subjects
The purpose of this paper is to establish the pharmacokinetics and safety of escalating, once-daily doses of daptomycin, a novel lipopeptide antibiotic active against gram-positive pathogens, including those resistant to methicillin and vancomycin. This phase 1, multiple-dose, double-blind study inv...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
2003
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC152488/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12654665/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.4.1318-1323.2003 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|